Bio-Rad Laboratories Class B
BIO.B
8 hedge funds and large institutions have $10.2M invested in Bio-Rad Laboratories Class B in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
33% more funds holding
Funds holding: 6 → 8 (+2)
12% more capital invested
Capital invested by funds: $9.14M → $10.2M (+$1.1M)
0.02% more ownership
Funds ownership: 0.62% → 0.64% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$250K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$62.3K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$28.8K |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
+$313 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $6.98M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $2.02M | – | – | – |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $486K | +$28.8K | +92 | +6% |
|
4
Renaissance Technologies
New York
| $327K | – | – | – |
|
|
5
Morgan Stanley
New York
| $250K | +$250K | +800 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $178K | +$62.3K | +199 | +54% |
|
7
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
|
AG
8
Advisor Group
Phoenix,
Arizona
| – | +$313 | +1 | New |
|
BIO.B Hedge Fund Activity: Q3 2018 in Review
8 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q3 2018, worth a combined $10.2M — up 12% from $9.14M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BIO.B positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $250K.
- 8 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q3 2018, up from 6 in Q2 2018.
- Funds reported $10.2M of Bio-Rad Laboratories Class B stock for Q3 2018, up 12% quarter-over-quarter.
- 2 funds opened new Bio-Rad Laboratories Class B positions in Q3 2018 and 0 closed out, a net change of +2 holders.
- The largest Bio-Rad Laboratories Class B buyer in Q3 2018 was Morgan Stanley, an estimated $250K added.
Based on aggregated 13F filings for Q3 2018.